Key Takeaways
- Resilient quarter in a tough industry: UTI was one of only two top-10 AMCs to grow AUM QoQ, with QAAUM up Rs 437 crore and market share rising to 5.94%. Core PAT grew 29% YoY to Rs 111 crore.
- Passive and SIP engines firing: ETF & Index AUM surged 46% YoY to Rs 65,199 crore, while SIP inflows grew 54% YoY, outpacing the industry's 37%. SIP book market share improved by 22-23 bps over FY22.
- Yield compression is structural, not alarming: Weighted average AMC yield slipped 1 bp QoQ to 40 bps, and management expects a further 1-2 bp dilution as lower-yield passive and fixed-income AUM outgrow the higher-yield active equity book.
- Cost levers are identified but slow-moving: Employee costs, at 61-63% of total expenses, will take 2-3 years to normalize toward 45-50%, driven primarily by natural retirement without replacement. A near-term tailwind exists from retirements over the next nine months.
- What to watch next quarter: Progress on capital allocation (buyback deliberation), the launch of UTI SDOF III by September, and whether the 1-2 bp yield dilution forecast materializes or accelerates.
AUM Growth & Market Position
- Top-10 outperformer: UTI was one of only two mutual funds among the top 10 to post QoQ QAAUM growth, adding Rs 437 crore. Closing AUM market share edged up 3 bps to 5.89%.
- Equity book: QAAUM grew 23.5% YoY to Rs 66,693 crore, though equity market share fell roughly 17 bps. Net sales as a percentage of industry net inflows stood at 4%, below the 5.2% market share, primarily due to lumpsum redemptions.
- Passive dominance: ETF & Index QAAUM recorded 46% YoY growth to Rs 65,199 crore, capturing 11.8% of industry net inflows in the category. Management expects this exponential growth trend to continue.
- SIP momentum: Live SIP folios rose 5.4% to 22.67 lakh, SIP AUM grew 14.6% YoY to Rs 17,788 crore, and SIP inflows rose 4.1% QoQ and 53.7% YoY. Gross SIP inflows grew at 53.7% versus the industry's 37.1%.
- Distribution reach: Gross sales market share improved in the banking channel (2.74% to 3.20%) and large MFDs (6.60% to 6.85%), while overall share held steady at ~3.90%. B30 penetration remained strong at 23.3% of Monthly Average AUM versus the industry's 16.6%.
Lakhotia: "Yes, while the industry had witnessed lesser NFOs where the pricing structure gets distorted but as far as the open-ended schemes are concerned the pricing ratios between the manufacturer and the distributor remain the same."
Yield Dynamics & Revenue Quality
- Yield dilution drivers: AMC margin yield fell 1 bp QoQ to 40 bps. Three structural forces are at work: fresh equity inflows coming at lower yields versus the stock AUM yield of 85-90 bps, exponential growth in ETF and Index AUM at 5-6 bps, and a deliberate focus on regaining fixed-income market share where yields are 25-28 bps.
- Forward expectation: Management expects a further 1-2 bp dilution in the coming quarters from these same three factors. Equity yields themselves remained stable at around 84 bps, similar to the prior quarter.
- Core PAT yield resilient: Core PAT yield remains strong at around 20 bps, and management does not see much dilution because of the ongoing cost-reduction exercise and operating leverage. The profit margin number has been improving quarter-on-quarter over the last 2-3 years.
- Fixed-income yield outlook: Weighted average yield on debt funds has been in the 25-28 bps range for 2-3 years and is expected to stay there for at least the next six months. As the interest rate cycle peaks, longer-duration products may become attractive and could improve market share.
- Equity yield improvement gated: Any rise in equity yields depends on rationalization of the commission structure across the industry, and a near-term increase is difficult because competitive pressure has not yet built in.
Lakhotia: "That depends on the rationalization of the commissions structure across the industry."
Subsidiary Performance
| Subsidiary | Trend | Commentary |
|---|---|---|
| UTI Retirement Solutions | ▲ Growing | AUM increased 14.5% on a closing basis to Rs 2,01,919 crore; PAT decreased 18.89% YoY to Rs 10.7 crore. Expected to continue growing and contributing. |
| UTI International | ▬ Mixed | Management fees rose 23% YoY to Rs 32 crore, but operating loss was Rs 15 crore (vs Rs 1 crore in Q4FY22) and PBT was Rs 16 crore negative due to mark-to-market loss on the IDEF investment. Offshore fund saw net positive flows of $250 million from April 2021 despite $25 billion in FII outflows from India. |
| UTI Capital | ▼ Loss-making | Net loss of Rs 1.2 crore in Q1FY23. Management expects it will take couple of more years to start contributing. |
- IDEF impairment view: The Rs 116 crore outstanding investment in IDEF has a current value of around Rs 257 crore, nearly double since inception. Management views the mark-to-market loss as temporary and is confident of a recovery, noting that growth stocks declined over the last six months.
- UTI International confidence: Management expressed strong confidence in AUM growth and operating profit improvement, citing new funds in the pipeline and good traction from international market performance. Core profit is expected to remain strong as market volatility settles.
Saha: "While IDEF has shown a negative return, it has almost doubled since inception. Like today cost wise it is Rs. 116 crores is outstanding, it values to around Rs. 257 crores. Thus, we get a good fees from it."
Cost Structure & Margin Levers
- Employee cost normalization path: Group employee cost stood at Rs 101 crore, up 7% YoY but down 12% QoQ from Rs 115 crore in Q4FY22. The YoY increase was mainly from staff cost increases at UTI International and UTI Retirement Solutions due to business restructuring.
- The 2-3 year journey: Management's stated goal is to bring employee costs down from the current 61-63% of total expenses to 45-50%, primarily through natural retirement without replacement. Core salary cost is expected to reduce over the next nine months as retirements flow through the pipeline.
- Variable and other costs: Variable cost will move in tandem with revenue and AUM growth. Insurance costs should decline based on rising interest rates. Overall, management sees a stabilizing trend in employee costs even after accounting for incremental annual wage hikes.
- Other expenses swing: Other expenses fell sharply QoQ from ~Rs 65 crore to ~Rs 49 crore, driven by four one-off factors: higher-than-anticipated variable pay in Q4, ~Rs 3 crore in BCG expenses for UTI Retirement hitting Q4, CSR expenses not yet fully accounted in Q1, and trail fee impacts in Q4.
- ESOP cost schedule: Rs 12.93 crore for FY23 (Rs 4.72 crore already in Q1), declining to Rs 3.78 crore in FY24 and Rs 0.84 crore in FY25.
Rahman: "UTI International is also a very stable subsidiary and this subsidiary will make a lot of money but whenever there is a M2M gain or loss it affects the profitability. But going forward, it appears as the outlook is, the market volatility will settle down and this company will continue to have the core profit very strong."
Product Pipeline & Strategic Initiatives
- Recent launches: UTI India Innovation Fund launched during Q1FY23, and a Gilt 10-year constant maturity fund was recently introduced.
- SEBI filings: Papers filed for passively managed debt index funds, an ETF, and an international fund of funds, all expected to launch in the coming quarters.
- UTI SDOF III: Approved by SEBI in April 2022 (rebranded from Growth Theme Fund I), with launch targeted by the September 2022 quarter.
- International expansion: Commenced operations from a new office in Paris, France, to strengthen the European foothold.
- Debt AUM headwind: Outflows in fixed-income categories were primarily from the closure and redemption of fixed maturity plans (FMPs) that have not been rolled out, as FMPs are currently out of favour given the interest rate environment.
Capital Allocation & Shareholder Returns
- Cash position under review: Management acknowledged it is sitting on excess cash and is exploring strategies to service it better in the interest of shareholders, including a potential buyback. No decision has been taken yet at the management level.
- Dividend consistency: The company paid a 67% dividend this time, up from 61% last year, and committed to being consistent in paying dividends. Discussions on the dividend payout will be taken up with the Board in due course.
- Timeline uncertainty: When pressed for a specific timeline on utilizing the ~Rs 1,500-1,800 crore cash pile, management said it will discuss internally with the Board and hopes to deliberate better in the next call. No firm commitment was given.
Rahman: "We are cognizant that we are sitting on cash and we are exploring the strategies how do we service this cash better in the interest of the shareholder."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Yield dilution | Further 1-2 bps decline in weighted average AMC yield from current 40 bps | Coming quarters |
| Fixed-income yield range | Weighted average yield to remain at 25-28 bps | At least next 6 months |
| UTI SDOF III launch | Fund to be launched in the market | By September 2022 quarter |
| Core salary cost reduction | Reduction driven by natural retirement pipeline | Next 9 months |
| Employee cost normalization | From 61-63% of total expenses to 45-50% | 2-3 years |
| ESOP cost decline | From Rs 12.93 cr in FY23 to Rs 3.78 cr in FY24 to Rs 0.84 cr in FY25 | FY23 through FY25 |
| UTI Capital contribution | Meaningful contribution expected | Couple more years |
| Capital allocation decision | Buyback or other options to be deliberated with Board | No specific timeline (hopefully next call) |
Key Metrics
| Metric | Q1 FY23 |
|---|---|
| Consolidated net profit | ₹94 cr |
| Consolidated core net profit | ₹111 cr, +29% YoY from ₹86 cr in Q1 FY22 |
| Standalone core PAT | ₹101 cr, +71% QoQ and +44% YoY |
| Standalone core income | ₹234 cr, +9% YoY and -2% QoQ |
| QAAUM | ₹2,24,279 cr, +19.80% YoY and +₹437 cr QoQ |
| QAAUM market share | 5.94%, up from 5.83% in Q4 FY22 |
| Closing AUM market share | 5.89%, up 3 bps from 5.86% as on March 31, 2022 |
| Weighted average AMC yield | 40 bps, down from 41 bps in Q4 FY22 |
| Core PAT yield | ~20 bps, remains strong |
| Net sales (UTI Mutual Fund) | ₹3,771 cr, industry saw outflow of ₹4,539 cr |
| Equity net inflows | ₹1,953 cr, 4% of industry net inflows, vs ₹975 cr in Q1 FY22 |
| ETFs and Index Funds net inflows | ₹4,854 cr, 11.8% of industry net inflows |
| SIP inflows | ₹1,550 cr, +4.1% QoQ and +53.66% YoY |
| SIP AUM | ₹17,788 cr, +14.59% YoY |
| Live SIP folios | 22.67 lakh, +5.44% QoQ |
| New SIPs registered | 2.58 lakh |
| Average SIP ticket size | ₹3,365 for June 2022 |
| Equity QAAUM | ₹66,693 cr, +23.49% YoY |
| Equity QAAUM market share | 5% |
| Index and ETFs QAAUM | ₹65,199 cr, +45.95% YoY |
| Hybrid funds net outflow | ₹164 cr |
| Gross sales market share | 8.5% of industry gross sales |
| B30 cities share of Monthly Average AUM | 23.3%, industry at 16.6% |
| Live folios | 1.20 cr, up from 1.19 cr as on March 31, 2022 |
| UTI Group total AUM | ₹13.82 lakh cr, +15% YoY |
| Employee cost (group) | ₹101 cr, +7% YoY and -12% QoQ |
| Operating profit margin as a percentage of AUM | 17 bps, vs 16 bps in Q1 FY22 |
| UTI Retirement Solutions AUM | ₹2,03,786 cr, +14.5% YoY, 27.37% industry share |
| UTI Retirement Solutions PAT | ₹10.7 cr, -18.89% YoY |
| UTI International management fees | ₹32 cr, +23% YoY |
| UTI International AUM | ₹25,990 cr as of June 30, 2022 |
| UTI Capital net loss | ₹1.2 cr |
| UTI Capital total AUM | ₹1,551 cr |
| Dividend payout | 67%, up from 61% last year; policy minimum 50% |
| Cash and investments on balance sheet | ~₹3,000 cr, ~35–40% of market cap (per an analyst's math) |